Table 3.

Platelet Adhesion to Collagen Type III of vWF; Addition of the Recombinant vWFs to Normal Whole Blood

SurfaceAdditionAnticoagulantCoverage as % of Control
CoII II WT Citrate 100 
 R543Q  19 ± 73-150 
 R543W  15 ± 73-150 
CoII III WT LMWH 100 
 R543Q  50 ± 83-151 
 R543W  73 ± 53-151 
vWF WT Citrate 100 
 R543Q  102 ± 7 
 R543W  98 ± 3 
SurfaceAdditionAnticoagulantCoverage as % of Control
CoII II WT Citrate 100 
 R543Q  19 ± 73-150 
 R543W  15 ± 73-150 
CoII III WT LMWH 100 
 R543Q  50 ± 83-151 
 R543W  73 ± 53-151 
vWF WT Citrate 100 
 R543Q  102 ± 7 
 R543W  98 ± 3 

Recombinant vWFs (WT, R543Q, and R543W) were added to citrated or LMWH anticoagulated whole blood at 0.5 μg/mL and perfusion was performed using collagen type III or vWF-coated coverslips. The coverslips were exposed to shear rate 1,600 s−1 for 5 minutes at 37°C. The data are mean ± SEM obtained in three independent experiments each performed in triplicate. The mean platelet coverage on CoII III in citrate for WT is 19%, on CoII III in LMWH is 42.3%, and on vWF 56.7%. The platelet count of the perfusates does not differ more than 10%.

F3-150

P < .01.

F3-151

P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal